News

company

year

domain

Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class

Abiologics 07.23.2024

Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability

07.10.2024

Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions

07.10.2024

KSQ Therapeutics Announces First Patient Dosed in Clinical Development Program for KSQ-001EX, a CRISPR/Cas9 Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy

KSQ Therapeutics 06.12.2024

Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer

ProFound™ Therapeutics 06.12.2024

Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management

Metaphore Biotechnologies 05.09.2024

Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral Proteome

Prologue Medicines 05.07.2024

Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases

Repertoire® Immune Medicines 04.29.2024

Flagship Appoints Amy O’Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences

Invaio Sciences 04.08.2024

Flagship Pioneering Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024

03.19.2024

Loading